contractor articles (853)
Active Articles:
A52571: Self-Administered Drug Exclusion List:A52575: Billing and coding information for prostate biopsies
A52578: Billing and coverage for drug wastage
A52598: 11730: Surgical treatment of nails-billing and coding clarification
A52600: 55876: Implanted Fiducial Markers—Coding and Billing Guidelines
A52603: Administration of Certain Biological Response Modifiers
A52604: 96521: Refilling and maintenance of portable pump
A52646: PROVENGE®: criteria for prepayment review
A52650: Signature requirements clarification
A53848: NCD - Pharmacogenomic Testing for Warfarin Response
A54674: Intravitreal Bevacizumab (Avastin®) Coding guidelines
A54680: Diagnostic Evaluation and Medical Management of Moderate-Severe Dry Eye Disease (DED) - coding guidelines
A54690: Bone mineral density studies revision to the Part A/B LCD
A54706: Visual field examination – revision to the Part A-B LCD
A54717: Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI) revision to LCD
A54718: Polysomnography and sleep testing – revision to the LCD
A54720: 3D Interpretation and Reporting of Imaging Studies revision to LCD
A54721: Cardiology-non-emergent outpatient testing: exercise stress test, stress echo, MPI SPECT, and cardiac PET revision to LCD
A54722: Erythropoiesis stimulating agents (J0881 and J0885) claims may have been denied in error
A54723: Bone mineral density studies revision to the LCD
A54724: Diagnostic colonoscopy revision to the LCD
A54757: Susceptibility studies revision to the LCD
A54763: Somatosensory testing revision to the Part B LCD
A54770: Self-administered drug (SAD) list Praluent® (alirocumab), repatha™ (evolocumab), and natpara® (parathyroid hormone) J3490/J3590/C9399
A54772: Visual field examination revision to the LCD
A54773: Excision of malignant skin lesions revision to the Part B LCD
A54792: Bone mineral density studies revision to the LCD
A54794: Percutaneous electrical nerve stimulation (PENS) and percutaneous neuromodulation therapy (PNT)
A54800: Chiropractic Services retired LCD
A54815: Noncovered Procedures - Endoscopic Treatment of Gastroesophageal Reflux Disease (GERD) coding guidelines
A54838: New requirement for CMS approved investigational device exemption (IDE) studies
A54871: Visual field examination revision to the LCD
A54872: Vitamin D; 25 hydroxy, includes fraction(s), if performed revision to the LCD
A54876: Transthoracic echocardiography (TTE) revision to the LCD
A54902: Bisphosphonates (intravenous [IV]) and monoclonal antibodies in the treatment of osteoporosis and their other indications revision to the LCD
A54904: Excision of Malignant Skin Lesions revision to the Part B LCD
A54905: Flow Cytometry revision to the Part AB LCD
A54913: Destruction of Malignant Skin Lesions revision to the Part B LCD
A54926: Billing and Coding: Single Chamber and Dual Chamber Permanent Cardiac Pacemakers
A54933: BRCA1 and BRCA2 Genetic Testing – New Part AB LCD
A54936: Vitamin D; 25 hydroxy, includes fraction(s), if performed revised Part A-B LCD
A54937: Botulinum Toxins– revision to the LCD
A54938: Computerized Corneal Topography revision to the Part B LCD
A54942: G-CSF (Neupogen®, Granix™, Zarxio™) clarification related to HCPCS code Q5101
A54951: Bisphosphonates (intravenous [IV]) and monoclonal antibodies in the treatment of osteoporosis and their other indications (HCPCS code J3489 [Reclast®]) revision to the Part A and Part B LCD
A54952: Genetic testing for lynch syndrome and special histochemical stains and immunohistochemical stains revision to the Part A and Part B LCDs
A54971: Botulinum toxins revision to the Part A and Part B LCD (J0585, J0588)
A54985: Intensity modulated radiation therapy (IMRT) retired Part A and Part B LCD
A55016: Hemophilia clotting factors revision to the Part A and Part B LCD
A55019: Self-administered drug (SAD) list revision to the Part A and Part B article: asfotase alfa (Strensiq™) J3490/J3590/C9399
A55020: Viscosupplementation therapy for knee revision to the Part A and Part B LCD
A55021: Screening mammography related to referring physician claims that may have been denied in error
A55022: Radiologic examination hip/femur services billed by portable x-ray suppliers – claims that may have been denied in error
A55032: Amniotic membrane sutureless placement on the ocular surface revision to the Part A and Part B LCD
A55065: Amniotic membrane sutureless placement on the ocular surface revision to the Part A and Part B LCD
A55067: Computed tomographic angiography, chest – claims that may have been denied in error (Part B)
A55108: G-CSF (Neupogen®, Granix™, Zarxio™) revision to the Part A and Part B LCD
A55119: Viscosupplementation therapy for knee arthrography to provide guidance for injections is non-covered
A55120: Medical review article for percutaneous minimally invasive fusion/stabilization of the sacroiliac joint
A55123: Botulinum toxinsrevision to the Part A and Part B LCD
A55125: Bone mineral density studies revision to the Part A and Part B LCD
A55126: Genetic testing for Lynch syndrome revision to the Part A and Part B LCD
A55127: Independent diagnostic testing facility (IDTF) revision to the LCD
A55128: Vitamin D; 25 hydroxy, includes fraction(s), if performed revision to the Part A and Part B LCD
A55153: Hemophilia clotting factors revision to LCD
A55226: Reduction mammoplasty revision to the Part B LCD
A55262: Computerized Corneal Topography revision to the Part B LCD
A55316: Intravenous Immune Globulin—revision to the Part AB LCD
A55322: Intravenous Immune Globulin—revision to the Part AB LCD
A55328: Aortography and peripheral angiography New Part A and Part B LCD
A55332: Computed tomographic angiography of the chest, heart and coronary arteries revision to the Part AB LCD
A55343: Amniotic membrane sutureless placement on the ocular surface - revision to the Part AB LCD
A55345: Transthoracic echocardiography (TTE) revision to the Part AB LCD
A55346: Bisphosphonates (intravenous [IV]) and monoclonal antibodies in the treatment of osteoporosis and their other indications
A55355: Hemophilia clotting factors revision to the Part AB LCD
A55356: Notification of Centers for Medicare & Medicaid Services (CMS) approval to First Coast Service Options for TAVR/TAMR
A55357: Computerized corneal topography claims may have been denied in error
A55365: Transthoracic Echocardiography (TTE) revision to the Part A and Part B LCD
A55366: Investigational device exemption (IDE) process for studies approved by the Centers for Medicare & Medicaid Services (CMS)
A55375: Application of skin substitute grafts for treatment of DFU and VLU of lower extremities overpayments resulting from claims processing issue
A55389: Application of skin substitute grafts clarification of billing when services are performed in the hospital outpatient setting
A55411: Coding article for positron emission tomography (PET) scans used for oncological indications
A55412: Non-invasive extracranial arterial studies revision to the Part A and Part B LCD
A55459: Controlled substance monitoring and drugs of abuse testing revision to the Part A and Part B LCD
A55460: Hyaluronan or derivative, Gel-Syn (HCPCS code J7328) clarification of billing
A55467: Viscosupplementation therapy for knee revision to the Part A and Part B LCD
A55477: Rezum® System for use in the management of benign prostatic hypertrophy clarification regarding the system technology and correct billing
A55497: Susceptibility studies revision to the Part A and Part B LCD
A55516: Viscosupplementation therapy for knee revision to the Part A and Part B LCD
A55551: Multiple Part B local coverage determinations (LCDs) being retired
A55572: Vinorelbine tartrate (Navelbine®) retired Part A and Part B LCD
A55581: Vitamin D; 25 hydroxy, includes fraction(s), if performed – revision to the Part A and Part B LCD
A55582: Eclipse system for the treatment of fecal incontinence in adult women clarification regarding the device technology and correct billing
A55588: Vascular endothelial growth factor inhibitors for the treatment of ophthalmological diseases — new Part A and Part B LCD
A55619: Epidural — revision to the Part B LCD
A55633: Biofeedback revision to the Part A and Part B LCD
A55638: Trastuzumab (Herceptin®) — revision to the Part A and Part B LCD
A55663: Label and off-label coverage of outpatient drugs and biologicals revision to the Part B LCD
A55713: Destruction of paravertebral facet joint nerve(s) — revision to the Part B LCD
A55714: Destruction of Paravertebral Facet Joint Nerve(s)
A55740: Vascular endothelial growth factor inhibitors for the treatment of ophthalmological diseases revision to the Part A and Part B LCD
A55742: Self-administered drug (SAD) list revision to the Part A and Part B article
A55757: Wound care (L37166): Medicare Part A/B local coverage determination (LCD) comment summary
A55767: Wound care – New Part A and Part B LCD
A55771: Psychological and neuropsychological tests revision to the Part A and B LCD
A55797: Upper Eyelid and Brow Surgical Procedures
A55799: Upper eyelid and brow surgical procedures revision to the Part A and Part B LCD
A55806: Response to Comments: BRCA1 and BRCA2 Genetic Testing
A55813: Response to Comments: Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower Extremities
A55818: Billing and Coding: Wound Care
A55819: Bisphosphonates (intravenous [IV]) and monoclonal antibodies in the treatment of osteoporosis and their other indications – revision to the Part A and Part B LCD
A55820: Serum phosphorus – revision to the Part A and Part B LCD
A55823: Scanning computerized ophthalmic diagnostic imaging (SCODI) revision to the Part A and B LCD
A55824: Response to Comments: L33751 Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
A55825: Response to Comments: L36324 Special Histochemical Stains and Immunohistochemical Stains
A55826: Electroretinography (ERG) – new Part A and Part B LCD
A55827: Response to Comments: Electroretinography ERG (L37398): Medicare Part A/B local coverage determination (LCD) comment summary
A55829: Cystatin C measurement new Part A and B LCD
A55830: Response to Comments: L37561 Cystatin C Measurement
A55831: Response to Comments: L33405 Polysomnography and Sleep testing
A55836: Long-term wearable electrocardiographic monitoring (WEM) revision to the Part A and Part B LCD
A55837: Wound care revision to the Part A and Part B LCD
A55838: Controlled substance monitoring and drugs of abuse testing revision to the Part A and Part B LCD
A55842: Computed tomographic angiography of the chest, heart and coronary arteries revision to the Part A and Part B LCD
A55854: Response to Comments: Intensity Modulated Radiation Therapy (IMRT), L36773
A55855: Response to Comments: Evaluation and Management Services in a Nursing Facility, L36230
A55856: Response to Comments: Aortography and peripheral angiography, L36767
A55860: Luteinizing hormone-releasing hormone (LHRH) analogs revision to the Part A and Part B LCD
A55862: Duplex scan of lower extremity arteries revision to the Part A and Part B LCD
A55863: Non-invasive physiologic studies of upper or lower extremity arteries revision to the Part A and Part B LCD
A55866: Magnetic resonance angiography (MRA) revision to the Part A and Part B LCD
A55867: Molecular pathology procedures for human leukocyte antigen (HLA) typing revision to the Part A and Part B LCD
A55868: Transcranial magnetic stimulation for major depressive disorder revision to the Part A and Part B LCD
A55871: Hemophilia clotting factors revision to the Part A and Part B LCD
A55874: Viscosupplementation therapy for knee revision to the Part A and Part B LCD
A55878: Controlled substance monitoring and drugs of abuse testing revision to the Part A and Part B LCD
A55884: Response to Comments: Treatment of varicose veins of the lower extremity, L33762
A55891: Reduction mammaplasty revision to the Part B LCD
A55892: Viscosupplementation therapy for knee revision to the Part A and Part B LCD
A55895: Ambulatory surgical center (ASC) inappropriate use of modifier 50
A55896: Destruction of Paravertebral Facet Joint Nerve(s) Coding Guideline
A55898: Self-administered drug (SAD) list revision to the Part A and Part B article
A55899: Major joint replacement (hip and knee) revision to the Part A and Part B LCD
A55906: Paravertebral facet joint blocks revision to the Part B LCD
A55920: Therapy and rehabilitation services revision to the Part A and Part B LCD
A55921: Therapy services billed by physicians/nonphysician practitioners revision to the Part B LCD
A55922: Luteinizing hormone-releasing hormone (LHRH) analogs revision to the Part A and Part B LCD
A55923: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs Coding Guidelines
A55927: Label and off-label coverage of outpatient drugs and biologicals revision to the Part B LCD
A55928: Peripheral nerve blocks revision to the Part B LCD
A55929: Polysomnography and sleep testing revision to the Part A and Part B LCD
A55930: Surgical management of morbid obesity revision to the Part A and Part B LCD
A55935: Diagnostic colonoscopy revision to the Part A and Part B LCD
A55937: Billing and Coding: Diagnostic Colonoscopy
A55939: Bone mineral density studies revision to the Part A and Part B LCD
A55941: CYP2C19, CYP2D6, CYP2C9, and VKORC1 genetic testing revision to the Part A and Part B LCD
A55942: G-CSF (Neupogen®, Granix™, Zarxio™) revision to the Part A and Part B LCD
A55943: Infliximab (Remicade™) revision to the Part A and Part B LCD
A55949: Biofeedback revision to the Part A and Part B LCD
A55952: Intravenous immune globulin revision to the Part A and Part B LCD
A55953: Magnetic resonance angiography (MRA) revision to the Part A and Part B LCD
A55960: Vertebroplasty, Vertebral Augmentation; Percutaneous Coding Guidelines
A55962: Therapy services billed by physicians/nonphysician practitioners revision to the Part B LCD
A55963: Treatment of varicose veins of the lower extremity revision to the Part A and Part B LCD
A55964: Botulinum toxins revision to the Part A and Part B LCD
A55966: Therapy and rehabilitation services revision to the Part A and Part B LCD
A55968: E&M home and domiciliary visits revision to the Part B LCD
A55969: Bone mineral density studies revision to the Part A and Part B LCD
A55975: Emergency and non-emergency ground ambulance services New Part A and Part B LCD
A55976: Response to Comments: Emergency and Non-Emergency Ground Ambulance Services
A55991: Vitamin D; 25 hydroxy, includes fraction(s), if performed revision to the Part A and Part B LCD
A55994: Molecular pathology procedures for human leukocyte antigen (HLA) typing revision to the Part A and Part B LCD
A56012: Bisphosphonates (intravenous [IV]) and monoclonal antibodies in the treatment of osteoporosis and their other indications – revision to the Part A and Part B LCD
A56031: Scanning computerized ophthalmic diagnostic imaging (SCODI) revision to the Part A and Part B LCD
A56047: Transcranial magnetic stimulation for major depressive disorder revision to the Part A and Part B LCD
A56049: Gene Expression Profiling Panel for use in the Management of Breast Cancer Treatment Coding Guideline
A56057: High sensitivity c-reactive protein (hsCRP) revision to the Part B LCD
A56063: Bisphosphonates (intravenous [IV]) and monoclonal antibodies in the treatment of osteoporosis and their other indications – revision to the Part A and Part B LCD
A56064: Treatment of varicose veins of the lower extremity revision to the Part A and Part B LCD
A56070: Emergency and non-emergency ground ambulance services revision to the Part A and Part B LCD
A56095: Mohs micrographic surgery (MMS) revision to the Part A and Part B LCD
A56096: Non-invasive extracranial arterial studies revision to the Part A and Part B LCD
A56099: Erythropoiesis stimulating agents revision to the Part A and Part B LCD
A56100: Erythropoiesis Stimulating Agents L36276 Coding Guidelines
A56102: Electroretinography (ERG) revision to the Part A and Part B LCD
A56116: Allergen immunotherapy – new Part B LCD
A56118: Response to Comments: DL37800 Allergen Immunotherapy
A56125: Humanitarian use device (HUD) and humanitarian device exemption (HDE) process revision to the Part A and Part B LCD
A56130: Emergency and non-emergency ground ambulance services revision to the Part A and Part B LCD
A56131: Duplex scan of lower extremity arteries revision to the Part A and Part B LCD
A56134: Incision and Drainage of Abscess of Skin, Subcutaneous and Accessory Structures Coding Guidelines
A56145: Pegfilgrastim (Neulasta®) revision to the Part A and B LCD
A56146: Erythropoiesis stimulating agents revision to the Part A and Part B LCD
A56153: Major joint replacement (hip and knee) revision to the Part A and Part B LCD
A56154: Electrocardiography revision to the Part A and Part B LCD
A56163: G-CSF (Neupogen®, Granix™, Zarxio™, Nivestym™) revision to the Part A and B LCD
A56176: Lumbar spinal fusion for instability and degenerative disc conditions revision to the Part A and Part B LCD
A56179: Insertion of anterior segment aqueous drainage device – Current Procedural Terminology (CPT®) codes 0191T, 0474T and 0449T
A56182: Surgical management of morbid obesity revision to the Part A and Part B LCD
A56183: Peripheral nerve blocks revision to the Part B LCD
A56185: Botulinum toxins revision to the Part A and B LCD
A56188: Pulmonary diagnostic services revision to the Part A and Part B LCD
A56196: Intravenous immune globulin revision to the Part A and Part B LCD
A56197: Psychological and neuropsychological tests revision to the Part A and Part B LCD
A56244: Self-administered drug (SAD) list revision to the Part A and Part B article
A56245: Therapy and rehabilitation services – revision to the Part A and Part B LCD
A56263: Response to Comments: Frequency of Hemodialysis L37564
A56264: Frequency of hemodialysis – new Part A and Part B LCD
A56276: Routine foot care revision to the Part B LCD
A56286: Noncovered service- 4kscore test algorithm – new Part A and Part B LCD
A56288: Response to Comments: Noncovered Service - 4Kscore Test Algorithm
A56290: Polysomnography and sleep testing revision to the Part A and Part B LCD
A56291: Duplex scan of lower extremity arteries revision to the Part A and Part B LCD
A56292: Diagnostic colonoscopy revision to the Part A and Part B LCD
A56293: Treatment of varicose veins of the lower extremity revision to the Part A and Part B LCD
A56294: Viscosupplementation therapy for the knee revision to the Part A and Part B LCD
A56295: Omalizumab (Xolair®) revision to the Part B LCD
A56296: Wireless capsule endoscopy revision to the Part A and Part B LCD
A56297: Destruction of paravertebral facet joint nerve(s) revision to the Part B LCD
A56298: E & M home and domiciliary visits revision to the Part B LCD
A56299: Independent diagnostic testing facility (IDTF) revision to the Part B LCD
A56300: Nail debridement revision to the Part B LCD
A56301: Vestibular function tests revision to the Part B LCD
A56302: Vitamin B12 injections revision to the Part B LCD
A56304: Scanning computerized ophthalmic diagnostic imaging (SCODI) revision to the Part A and Part B LCD
A56305: Magnetic resonance angiography revision to the Part A and Part B LCD
A56306: Transcranial magnetic stimulation for major depressive disorder revision to the Part A and Part B LCD
A56308: CYP2C19, CYP2D6, CYP2C9, and VKORC1 genetic testing revision to the Part A and Part B LCD
A56309: Spinal cord stimulation for chronic pain revision to the Part A and Part B LCD
A56310: Special histochemical stains & immunohistochemical stains revision to the Part A and Part B LCD
A56312: Electroretinography revision to the Part A and Part B LCD
A56319: Bone mineral density studies revision to the Part A and Part B LCD
A56320: Allergy testing revision to the Part A and Part B LCD
A56339: Frequency of hemodialysis – new Part A and Part B LCD
A56341: Billing and Coding: Implantable Automatic Defibrillators
A56349: Intravenous immune globulin revision to the Part A and Part B LCD
A56350: Revisions to multiple Part A and Part B LCDs
A56351: Revision to multiple Part B LCDs
A56475: Medicare Part B clinical lab fee schedule (CLFS): revised information for laboratories on laboratory organ or disease panel billing requirements
A56481: Hemophilia clotting factors revision to the Part A and Part B LCD
A56482: Billing and Coding: Hemophilia Clotting Factors
A56483: Bone mineral density studies revision to the Part A and Part B LCD
A56484: Billing and Coding: Bone Mineral Density Studies
A56486: Laboratory Panels – Coding and Billing
A56487: Diagnostic colonoscopy and colorectal cancer screening revisions to the Part A and Part B LCDs
A56519: E&M home and domiciliary visits revision to the Part B LCD
A56525: Noncovered service – dopamine transporter single-photon emission computed tomography (DAT-SPECT) with iodine I-123 ioflupane retired Part A and Part B LCD
A56638: Billing and Coding: Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)
A56644: Billing and Coding: Endovenous Stenting
A56647: Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS)
A56649: Bone mineral density studies revision to the Part A and Part B LCD
A56650: Epidural revisions to the Part B LCD
A56651: Billing and Coding: Epidural
A56652: Hemophilia clotting factors revision to the Part A and Part B LCD
A56655: Anorectal manometry and electromyography (EMG) of the urinary and anal sphincters – new Part A and Part B LCD
A56656: Response to Comments: DL37943 Anorectal Manometry and Electromyography (EMG) of the Urinary and Anal Sphincters
A56659: Trastuzumab (Herceptin®) revisions to the Part A and Part B LCD
A56660: Billing and Coding: Trastuzumab – Trastuzumab Biologics
A56664: Frequency of hemodialysis revision to Part A and Part B LCD
A56666: Billing and Coding: Frequency of Hemodialysis
A56705: Wireless capsule endoscopy revision to the Part A and Part B LCD
A56715: Vascular endothelial growth factor inhibitors for the treatment of ophthalmological diseases revision to the Part A and Part B LCD
A56716: Billing and Coding: Vascular Endothelial Growth Factor Inhibitors for the Treatment of Ophthalmological Diseases
A56738: Intensity modulated radiation therapy (IMRT) revision to the Part A and Part B LCD
A56741: Label and off-label coverage of outpatient drugs and biologicals revision to the Part B LCD
A56788: E&M home and domiciliary visits revision to the Part B LCD
A56789: Fulvestrant (Faslodex®) retired Part A and Part B LCD
A56790: Monitored anesthesia care (MAC) for certain interventional pain management services retired Part A and Part B LCD
A56812: Diagnostic colonoscopy revision to the Part A and Part B LCD
A56840: Vitamin D; 25 hydroxy, includes fraction(s), if performed revision to the Part A and Part B LCD
A56841: Billing and Coding: Vitamin D; 25 hydroxy, includes fraction(s), if performed
A56846: Intravenous immune globulin revision to the Part A and Part B LCD
A56919: 3D interpretation and reporting of imaging studies revision to the Part A and Part B LCD
A56945: Testosterone pellets (Testopel®) retired Part A and Part B LCD
A56952: Billing and Coding: Cardiology Non-emergent Outpatient Stress Testing
A56953: Billing and Coding: Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
A56994: Colorectal cancer screening retired Part A and Part B LCD
A57025: Billing and Coding: Upper Eyelid and Brow Surgical Procedures
A57027: Upper eyelid and brow surgical procedures revision to the Part A and Part B LCD
A57028: Ultrasound, soft tissues of head and neck revision to the Part A and Part B LCD
A57029: Billing and Coding: Ultrasound, Soft Tissues of Head and Neck
A57045: 2020 ICD-10-CM Coding Changes (Part A/B, Part A and Part B)
A57061: Billing and Coding: Computed Tomographic Angiography of the Chest, Heart and Coronary Arteries
A57062: Billing and Coding: Long-Term Wearable Electrocardiographic Monitoring (WEM)
A57063: Billing and Coding: Diagnostic and Therapeutic Esophagogastroduodenoscopy
A57064: Billing and Coding: Duplex Scan Of Lower Extremity Arteries
A57066: Billing and Coding: Electrocardiography
A57077: Billing and Coding: Controlled Substance Monitoring and Drugs of Abuse Testing
A57078: Single chamber and dual chamber permanent cardiac pacemakers billing and coding for Part A and Part B
A57080: Implantable automatic defibrillators billing and coding for Part A and Part B
A57088: Bone mineral density studies revision to the Part A and Part B LCD
A57114: Billing and Coding: Injection of Trigger Points
A57115: Billing and Coding: Noninvasive Ear or Pulse Oximetry For Oxygen Saturation
A57118: Billing and Coding: Vestibular Function Tests
A57120: Billing and Coding: Ionized Calcium
A57121: Billing and Coding: Magnesium
A57122: Billing and Coding: Parathormone (Parathyroid Hormone)
A57123: Billing and Coding: Nerve Conduction Studies and Electromyography
A57125: Billing and Coding: Non-Invasive Evaluation of Extremity Veins
A57126: Billing and Coding: Noninvasive Physiologic Studies of Upper or Lower Extremity Arteries
A57127: Billing and Coding: Pulmonary Diagnostic Services
A57145: Billing and Coding: Surgical Management of Morbid Obesity
A57156: Billing and Coding: Therapy and Rehabilitation Services
A57176: Billing and Coding: Susceptibility Studies
A57179: Billing and Coding: Transesophageal Echocardiogram
A57180: Billing and Coding: Vascular Stenting of Lower Extremity Arteries
A57182: Billing and Coding: Transthoracic Echocardiography (TTE)
A57188: Billing and Coding: Routine Foot Care
A57228: Independent diagnostic testing facility revision to the Part B LCD
A57256: Billing and Coding: Viscosupplementation Therapy For Knee
A57271: Stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) revision to the Part A and Part B LCD
A57272: Trastuzumab – trastuzumab biologics revision to the Part A and Part B LCD
A57273: Vascular endothelial growth factor inhibitors for the treatment of ophthalmological diseases revision to the Part A and Part B LCD
A57274: Viscosupplementation therapy for knee revision to the Part A and Part B LCD
A57275: Billing and Coding: Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT)
A57396: Frequency of hemodialysis revision to Part A and Part B billing and coding Article
A57438: BRCA1 and BRCA2 genetic testing revision to the Part A and Part B LCD
A57439: Genetic testing for lynch syndrome revision to the Part A and Part B LCD
A57440: Molecular pathology procedures revision to the Part A and Part B LCD
A57449: Billing and Coding: BRCA1 and BRCA2 Genetic Testing
A57450: Billing and Coding: Genetic Testing for Lynch Syndrome
A57451: Billing and Coding: Molecular Pathology Procedures
A57488: Azacitidine (Vidaza®) retired Part A and Part B LCD
A57489: Bendamustine hydrochloride retired Part A and Part B LCD
A57490: Gemcitabine (Gemzar®) retired Part A and Part B LCD
A57491: Erythropoiesis stimulating agents revision to the Part A and Part B LCD
A57493: Transcranial doppler studies revision to the Part B LCD
A57495: Polysomnography and sleep testing revision to the Part A and Part B LCD
A57496: Billing and Coding: Polysomnography and Sleep Testing
A57501: Self-administered drug (SAD) list revision to the Part A and Part B article
A57519: Psychiatric diagnostic evaluation and psychotherapy services revision to the Part A and Part B LCD
A57520: Billing and Coding: Psychiatric Diagnostic Evaluation and Psychotherapy Services
A57531: Billing and Coding: Allergy Testing
A57532: Reduction mammaplasty revision to the Part B LCD
A57535: Somatosensory testing revision to the Part B LCD
A57538: Billing and Coding: Reduction Mammaplasty
A57540: Billing and Coding: Somatosensory Testing
A57550: Allergy testing revision to the Part A and Part B LCD
A57602: Bisphosphonates (intravenous [IV]) and monoclonal antibodies in the treatment of osteoporosis and their other indications revision to the Part A and Part B LCD
A57603: Billing and Coding: Bisphosphonates (Intravenous [IV]) and Monoclonal Antibodies in the Treatment of Osteoporosis and Their Other Indications
A57628: Billing and Coding: Erythropoiesis Stimulating Agents
A57633: Billing and Coding: Transcranial Doppler Studies
A57634: Billing and Coding: Biventricular Pacing/ Cardiac Resynchronization Therapy
A57635: Billing and Coding: Biofeedback
A57636: Billing and Coding: Duplex Scanning
A57637: Billing and Coding: Visual Field Examination
A57638: Billing and Coding: Destruction of Malignant Skin Lesions
A57639: Billing and Coding: Destruction of Paravertebral Facet Joint Nerve(s)
A57647: Billing and Coding: Transcranial Magnetic Stimulation for Major Depressive Disorder
A57649: Billing and Coding: B-Type Natriuretic Peptide (BNP)
A57650: Billing and Coding: Serum Phosphorus
A57651: Billing and Coding: Autonomic Function Tests
A57653: Billing and Coding: Infliximab
A57654: Billing and Coding: Lumbar Spinal Fusion for Instability and Degenerative Disc Conditions
A57655: Billing and Coding: Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
A57657: Billing and Coding: Sedimentation Rate, Erythrocyte
A57658: Billing and Coding: Omalizumab
A57659: Billing and Coding: Humanitarian Use Device (HUD) and Humanitarian Device Exemption (HDE) process
A57660: Billing and Coding: Excision of Malignant Skin Lesions
A57666: Billing and Coding: Surgical Treatment of Nails
A57667: Billing and Coding: Special EEG Tests
A57669: Billing and Coding: Proton Beam Radiotherapy
A57670: Billing and Coding: Non-invasive Extracranial Arterial Studies
A57671: Proton beam radiotherapy revision to the Part B LCD
A57672: Billing and Coding: Nail Debridement
A57674: Billing and Coding: Emergency and Non-Emergency Ground Ambulance Services
A57677: Billing and Coding: Electroretinography (ERG)
A57678: Billing and Coding: Allergen Immunotherapy
A57679: Billing and Coding: Amniotic Membrane- Sutureless Placement on the Ocular Surface
A57680: Billing and Coding: Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower Extremities
A57682: Billing and Coding: Cystatin C Measurement
A57699: Billing and Coding: Computerized Corneal Topography
A57700: Billing and Coding: Therapy Services billed by Physicians/Nonphysician Practitioners
A57704: Billing and Coding: CYP2C19, CYP2D6, CYP2C9, and VKORC1 Genetic Testing
A57708: Billing and Coding: Special Histochemical Stains & Immunohistochemical Stains
A57709: Billing and Coding: Spinal Cord Stimulation for Chronic Pain
A57715: Billing and Coding: Botulinum Toxins
A57716: Billing and Coding: Flow Cytometry
A57722: Multiple Part A and Part B LCDs being retired
A57723: Multiple Part B LCDs being retired
A57724: Billing and Coding: Evaluation and Management Services in a Nursing Facility
A57725: Billing and Coding: Pegfilgrastim
A57730: Response to Comments: Endovenous Stenting
A57731: Endovenous stenting – new Part A and Part B LCD
A57737: Response to Comments: Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)
A57738: Gastrointestinal pathogen (GIP) panels utilizing multiplex nucleic acid amplification techniques (NAATs) – new Part A and Part B LCD
A57739: Micro-invasive glaucoma surgery (MIGS) – new Part A and Part B LCD
A57740: Response to Comments: Micro-Invasive Glaucoma Surgery (MIGS)
A57754: Billing and Coding: Health and Behavior Assessment/Intervention
A57755: Billing and Coding: Vitamin B12 Injections
A57763: Response to Comments: 4Kscore Test Algorithm
A57764: 4Kscore test algorithm revision to the Part A and Part B LCD
A57765: Billing and Coding: Major Joint Replacement (Hip and Knee)
A57767: Billing and Coding: Mohs Micrographic Surgery (MMS)
A57768: Billing and Coding: Molecular Pathology Procedures for Human Leukocyte Antigen (HLA) Typing
A57770: Billing and Coding: Posterior Tibial Nerve Stimulation (PTNS)
A57778: Billing and Coding: Intravenous Immune Globulin
A57779: Billing and Coding: Magnetic Resonance Angiography (MRA)
A57780: Billing and Coding: Psychological and Neuropsychological Tests
A57782: Treatment of varicose veins of the lower extremity revision to the Part A and Part B LCD
A57783: Billing and Coding: Incision and Drainage of Abscess of Skin, Subcutaneous and Accessory Structures
A57786: Billing and Coding: Osteopathic Manipulative Treatment
A57787: Billing and Coding: Paravertebral Facet Joint Blocks
A57788: Billing and Coding: Peripheral Nerve Blocks
A57789: Billing and Coding: G-CSF Filgrastim
A57793: Multiple LCD Revisions – Part A and Part B
A57802: Billing and Coding: Hepatic (Liver) Function Panel
A57803: Billing and Coding: High Sensitivity C-Reactive Protein (hsCRP)
A57804: Billing and Coding: Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
A57806: Independent diagnostic testing facility (IDTF) revision to the Part B LCD
A57807: Billing and Coding: Independent Diagnostic Testing Facility (IDTF)
A57853: National noncovered services revision to the Part A and Part B Billing and Coding Article
A57855: 2020 HCPCS Part A/B, Part A and Part B billing and coding article changes
A57857: Bone mineral density studies revision to the Part A and Part B Billing and Coding Article
A57872: Billing and Coding: Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
A57884: Billing and Coding: Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor
A57925: Independent diagnostic testing facility (IDTF) revision to the Part B Billing and Coding Article
A57939: Viscosupplementation therapy for knee revision to the Part A and Part B Billing and Coding Article
A57955: Trastuzumab – trastuzumab biologics revision to the Part A and Part B Billing and Coding Article
A57958: Response to Comments: Cardiology Non-emergent Outpatient Stress Testing
A57959: Response to Comments: Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
A57960: Cardiology non-emergent outpatient stress testing – new Part A and Part B LCD
A57961: Hypoglossal nerve stimulation for the treatment of obstructive sleep apnea – new Part A and Part B LCD
A57968: BRCA1 and BRCA2 genetic testing revision to the Part A and Part B Billing and Coding Article
A57977: Hepatitis B surface antibody and surface antigen retirement to the Part A and Part B LCD and Billing and Coding Article
A57978: Multiple Part A and Part B LCDs being retired
A57984: Therapy and rehabilitation services revision to the Part A and Part B Billing and Coding Article
A57985: BRCA1 and BRCA2 genetic testing revision to the Part A and Part B Billing and Coding Article
A57986: Major joint replacement (hip and knee) revision to the Part A and Part B Billing and Coding Article
A57987: Vascular endothelial growth factor inhibitors for the treatment of ophthalmological diseases revision to the Part A and Part B Billing and Coding Article
A57990: Trastuzumab – trastuzumab biologics revision to the Part A and Part B Billing and Coding Article
A57992: Peripheral nerve blocks revision to Part B Billing and Coding Article
A57993: Pegfilgrastim revision to the Part A and Part B Local Coverage Determination and Billing and Coding Article
A57995: Stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) – revision to the Part A and Part B LCD and Billing and Coding Article
A57996: Response to Comments: Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy
A58003: Multiple Part B LCDs being retired
A58004: Revision to the Part A and Part B Billing and Coding Article A57077
A58013: Revision to the Part A and Part B billing and coding article A57778
A58015: Revision to the Part A and Part B article A52571
A58041: Revision to the Part A and Part B billing and coding article A56484
A58042: Multiple Part B LCDs and billing and coding articles being retired
A58054: Pegfilgrastim - revision to the Part A and Part B billing and coding article
A58055: Transthoracic echocardiography (TTE) - revision to the Part A and Part B billing and coding article
A58056: Allergy testing - revision to the Part A and Part B billing and coding article
A58057: Molecular pathology procedures - revision to the Part A and Part B billing and coding article
A58066: Multiple Part A and Part B LCDs and billing and coding articles being retired
A58067: Manipulation under anesthesia - retired Part A and Part B LCD and billing and coding article
A58074: Prostatic urethral lift (PUL) - retired Part A and Part B LCD and billing and coding article
A58105: Paravertebral facet joint blocks – revision to the Part B LCD
A58106: Multiple Part A and Part B LCDs and billing and coding articles being retired
A58107: Scanning computerized ophthalmic diagnostic imaging (SCODI) - revision to the Part A and Part B Billing and Coding Article
A58134: Micro-invasive glaucoma surgery (MIGS) - revision to the Part A and Part B Billing and Coding Article
A58136: Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM)
A58148: Multiple Part B LCDs and billing and coding articles being retired
A58160: Gene expression profiling panel for use in the management of breast cancer treatment - retired Part A and Part B LCD and billing and coding article
A58173: Independent diagnostic testing facility (IDTF) - revision to the Part B billing and coding article
A58199: Magnetic-resonance-guided focused ultrasound surgery (MRgFUS) for essential tremor - new Part A and Part B LCD/billing and coding article
A58200: Percutaneous vertebral augmentation (PVA) for vertebral compression fracture (VCF) - revision to the Part A and Part B LCD
A58220: Response to Comments: Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor
A58221: Response to Comments: Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
A58232: Billing and Coding: Screening for Cervical Cancer with Human Papillomavirus (HPV)
A58233: Screening for cervical cancer for human papillomavirus (HPV) screening — New Part A and Part B Billing and Coding Article
A58234: Epidural - revision to the Part B billing and coding article
A58250: Billing and Coding: Treatment of Chronic Venous Insufficiency of the Lower Extremities
A58251: Respiratory therapeutic services – retired Part A and Part B LCD/billing and coding article
A58252: Allergy testing – revision to Part A and Part B LCD/billing and coding article
A58253: CYP2C19, CYP2D6, CYP2C9, and VKORC1 genetic testing - revision to the Part A and Part B LCD/billing and coding article
A58254: Diagnostic evaluation and medical management of moderate-severe dry eye disease (DED) — retired Part A and Part B LCD/billing and coding article
A58255: Noncovered services - retired Part A and Part B LCD/billing and coding article
A58256: Psychological and neuropsychological tests - revision to the Part A and Part B LCD
A58257: Psychiatric diagnostic evaluation and psychotherapy services - revision to the Part A and Part B LCD
A58258: Magnetic Resonance Angiography (MRA) – revision to Part A and Part B LCD/billing and coding article
A58259: Polysomnography and sleep testing– revision to the Part A and Part B LCD/billing and coding article
A58260: Pulmonary diagnostic services – revision to Part A and Part B LCD/billing and coding article
A58261: Treatment of varicose veins of the lower extremity – revision to Part A and Part B billing and coding article
A58262: Dysphagia/swallowing diagnosis and therapy - retired Part A and Part B LCD/billing and coding article
A58264: Billing and Coding: Transurethral Waterjet Ablation of the Prostate
A58268: Endovenous stenting – revision to Part A and Part B billing and coding article
A58302: Strapping- retired Part A and Part B LCD/Billing and Coding Article
A58303: Wound care - revision to the Part A and Part B LCD
A58309: Allergy testing – revision to Part A and Part B billing and coding article
A58310: Hemophilia clotting factors - revision to the Part A and Part B billing and coding article
A58312: Independent diagnostic testing facility (IDTF) - revision to the Part B billing and coding article
A58313: Infliximab - revision to the Part A and Part B billing and coding article
A58314: Pegfilgrastim - revision to the Part A and Part B billing and coding article
A58315: Viscosupplementation therapy for knee – revision to Part A and Part B billing and coding article
A58319: Nerve conduction studies and electromyography - revision to the Part A and Part B billing and coding article
A58326: Trastuzumab - trastuzumab biologics - revision to the Part A and Part B billing and coding article
A58365: Gastrointestinal pathogen (GIP) panels utilizing multiplex nucleic acid amplification techniques (NAATs) - revision to the Part A and Part B billing and coding article
A58372: Application of skin substitute grafts for treatment of DFU and VLU of lower extremities - revision to the Part A and Part B billing and coding article
A58386: Sacral neuromodulation - retired Part B LCD/billing and coding article
A58407: Implantable continuous glucose monitors (I-CGM) - new Part A and Part B LCD and billing and coding article
A58408: Response to Comments: DL38664 Implantable Continuous Glucose Monitors (I-CGM)
A58411: Chiropractic services - new Part A and Part B billing and coding article
A58412: Billing and Coding: Chiropractic Services
A58429: Hyperbaric oxygen (HBO) therapy - retired Part A and Part B LCD/billing and coding article
A58447: Independent diagnostic testing facility (IDTF) - revision to the Part B billing and coding article
A58458: Syphilis test - retired Part A and Part B LCD/billing and coding article
A58460: 2021 ICD-10-CM Coding Changes (Part A/B, Part A and Part B)
A58461: Chiropractic services - retired Part A and Part B LCD/billing and coding article
A58469: Infliximab - revision to the Part A and Part B billing and coding article
A58530: Response to Comments: Treatment of Chronic Venous Insufficiency of the Lower Extremities
A58531: Response to Comments: Endovenous Stenting
A58537: Response to Comments: Transurethral Waterjet Ablation of the Prostate
A58543: Billing and Coding: Urodynamic Services - Non-invasive
Quick, Current, Complete - www.findacode.com